Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @ZolmaxNews | 8 |
| @WatchlistN | 6 |
| @WeekHerald | 5 |
| @dailypoliticaln | 5 |
| @TickerReport | 5 |
Recent Tweets for GLMD
 |
@dailypoliticaln Galmed Pharmaceuticals $GLMD Expected to Post Quarterly Sales of $290,000.00 https://t.co/xC3WOLDc4r May 23rd 2018, 9:05pm |
 |
@ledgerzette -$0.15 Earnings Per Share Expected for Galmed Pharmaceuticals $GLMD This Quarter https://t.co/FLsrKQxrSK May 23rd 2018, 9:05pm |
 |
@WatchlistN -$0.15 Earnings Per Share Expected for Galmed Pharmaceuticals $GLMD This Quarter https://t.co/mmqg4gHe8O May 23rd 2018, 9:05pm |
 |
@TickerReport -$0.15 EPS Expected for Galmed Pharmaceuticals $GLMD This Quarter https://t.co/lrXTPMJMpC May 23rd 2018, 9:05pm |
 |
@ZolmaxNews Brokerages Expect Galmed Pharmaceuticals $GLMD Will Post Quarterly Sales of $290,000.00 https://t.co/2N1uJpWZD3 May 23rd 2018, 9:05pm |
 |
@DukeDiligence @adamfeuerstein any thoughts on $glmd and forthcoming p2b data? Thanks May 21st 2018, 3:05pm |
 |
@WeekHerald $290,000.00 in Sales Expected for Galmed Pharmaceuticals $GLMD This Quarter https://t.co/gAxjYIGhXX May 21st 2018, 3:05pm |
 |
@TheMarketsDaily Zacks: Brokerages Expect Galmed Pharmaceuticals $GLMD to Post -$0.15 Earnings Per Share https://t.co/K9SuNhzPBI May 21st 2018, 2:05pm |
 |
@dakotafinancial Galmed Pharmaceuticals $GLMD Expected to Announce Quarterly Sales of $290,000.00 https://t.co/8iHyqgydDR May 21st 2018, 2:05pm |
 |
@registrarjourn Zacks: Brokerages Expect Galmed Pharmaceuticals $GLMD to Post -$0.15 Earnings Per Share https://t.co/0toJOTCTyQ May 21st 2018, 2:05pm |
 |
@a_humdinger Dear $glmd, with data release roughly 3 weeks away... how are you not creeping up?!?! ????? Asking for a friend May 20th 2018, 4:05pm |
|
@ZolmaxNews Brokerages Expect Galmed Pharmaceuticals $GLMD Will Post Earnings of -$0.15 Per Share https://t.co/3CJDlU1xm7 May 19th 2018, 12:05pm |
 |
@ConsumerFeed Galmed Pharmaceuticals $GLMD Stock Rating Upgraded by Zacks Investment Research https://t.co/RZPLrwhEhe May 19th 2018, 3:05am |
|
@WatchlistN Galmed Pharmaceuticals $GLMD Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS https://t.co/IpuhvXTYHK May 18th 2018, 5:05pm |
 |
@TopTickrs RT @WatchlistN: Galmed Pharmaceuticals $GLMD Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS https://t.co/PVOn15dNQp May 18th 2018, 5:05pm |
|
@WatchlistN Galmed Pharmaceuticals $GLMD Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS https://t.co/PVOn15dNQp May 18th 2018, 5:05pm |
|
@TickerReport Galmed Pharmaceuticals $GLMD Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS https://t.co/JWtnC8wco4 May 18th 2018, 5:05pm |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Announces Quarterly Earnings Results https://t.co/6MjdVBq1Wq May 18th 2018, 4:05pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Issues Quarterly Earnings Results https://t.co/gqxXF2ZdYh May 18th 2018, 4:05pm |
|
@TickerReport Galmed Pharmaceuticals $GLMD Announces Earnings Results, Beats Estimates By $0.06 EPS https://t.co/vsla8F1L7m May 18th 2018, 4:05pm |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Announces Earnings Results, Beats Expectations By $0.06 EPS https://t.co/frQxPE6kfl May 18th 2018, 4:05pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Announces Earnings Results https://t.co/E1XOPY2P6H May 18th 2018, 4:05pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS https://t.co/ZbtUdZWtCL May 18th 2018, 3:05pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Issues Quarterly Earnings Results https://t.co/hIEosKK4vS May 18th 2018, 2:05pm |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Upgraded at Zacks Investment Research https://t.co/GWyeeRbkWx May 18th 2018, 2:05pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Upgraded to “Buy” at Zacks Investment Research https://t.co/WuZH667Cwf May 18th 2018, 2:05pm |
|
@WatchlistN Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Estimates By $0.06 EPS https://t.co/nAB4TMAb8r May 18th 2018, 1:05pm |
|
@registrarjourn Brokerages Anticipate Galmed Pharmaceuticals $GLMD Will Post Quarterly Sales of $290,000.00 https://t.co/ovQWsEq7h2 May 18th 2018, 6:05am |
 |
@AmericanBanking Brokerages Anticipate Galmed Pharmaceuticals $GLMD Will Post Quarterly Sales of $290,000.00 https://t.co/GDnaQ53O8Y #stocks May 18th 2018, 3:05am |
|
@TheMarketsDaily Brokerages Anticipate Galmed Pharmaceuticals $GLMD Will Post Quarterly Sales of $290,000.00 https://t.co/myYvHrRWHy May 18th 2018, 3:05am |
|
@registrarjourn Galmed Pharmaceuticals $GLMD Stock Rating Upgraded by Zacks Investment Research https://t.co/UsQq0hKHkt May 17th 2018, 6:05am |
 |
@dispatchtribune Galmed Pharmaceuticals $GLMD Lifted to “Buy” at Zacks Investment Research https://t.co/ccge9hIEqQ May 17th 2018, 1:05am |
|
@WeekHerald Galmed Pharmaceuticals $GLMD Receives $22.25 Consensus Target Price from Brokerages https://t.co/CsOWOc0LoN May 16th 2018, 7:05pm |
|
@ConsumerFeed Galmed Pharmaceuticals $GLMD Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS https://t.co/Z1jI1hM7vo May 16th 2018, 2:05pm |
 |
@OlympiaReport Galmed Pharmaceuticals $GLMD Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS https://t.co/KJxPZiuKvC May 16th 2018, 2:05pm |
|
@AmericanBanking Galmed Pharmaceuticals $GLMD Expected to Announce Earnings of -$0.15 Per Share https://t.co/FvHzomRu0P #stocks May 16th 2018, 1:05pm |
|
@WeekHerald Galmed Pharmaceuticals $GLMD Expected to Announce Earnings of -$0.15 Per Share https://t.co/bingsPfqWj May 16th 2018, 11:05am |
|
@WatchlistN Galmed Pharmaceuticals $GLMD Upgraded by Zacks Investment Research to Buy https://t.co/Q3gsH32kiN May 16th 2018, 9:05am |
|
@TickerReport Galmed Pharmaceuticals $GLMD Upgraded by Zacks Investment Research to Buy https://t.co/yVD3sMxhHg May 16th 2018, 9:05am |
|
@ledgerzette Galmed Pharmaceuticals $GLMD Upgraded by Zacks Investment Research to Buy https://t.co/O25s9yqYi7 May 16th 2018, 6:05am |
|
@AmericanBanking Galmed Pharmaceuticals $GLMD Upgraded by Zacks Investment Research to Buy https://t.co/Etk08qRQ6o #stocks May 15th 2018, 2:05pm |
|
@WeekHerald Galmed Pharmaceuticals $GLMD Upgraded to Buy by Zacks Investment Research https://t.co/mbwZFMfrlZ May 15th 2018, 6:05am |
 |
@RatingsNetwork Galmed Pharmaceuticals upgraded by Zacks Investment Research to buy. $6.50 PT. https://t.co/Qu2QfVS7QC $GLMD #GLMD May 15th 2018, 3:05am |
|
@dakotafinancial Galmed Pharmaceuticals $GLMD Upgraded to Buy by Zacks Investment Research https://t.co/KnuKS6oZ48 May 15th 2018, 1:05am |
|
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Upgraded to Buy by Zacks Investment Research https://t.co/4VJVzRQYGi May 15th 2018, 1:05am |
|
@ledgerzette Galmed Pharmaceuticals $GLMD Given Average Rating of “Buy” by Brokerages https://t.co/etA7pTTlEr May 14th 2018, 1:05pm |
 |
@TranscriptDaily Galmed Pharmaceuticals $GLMD Given Average Rating of “Buy” by Brokerages https://t.co/gh0x8lUvV7 May 14th 2018, 1:05pm |
|
@WatchlistN Galmed Pharmaceuticals $GLMD Earns Daily News Sentiment Rating of 0.21 https://t.co/dnLTxpkA04 May 14th 2018, 12:05pm |
|
@TickerReport Somewhat Positive Press Coverage Somewhat Unlikely to Impact Galmed Pharmaceuticals $GLMD Stock Price https://t.co/qSAl0UM7t1 May 14th 2018, 12:05pm |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Given a $14.00 Price Target at Maxim Group https://t.co/BzZ8IZNrJJ May 13th 2018, 3:05pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.